含有三环5:7:5稠合二咪唑并二氮杂卓环系的新型广谱抗癌剂。
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.
作者信息
Kondaskar Atul, Kondaskar Shilpi, Kumar Raj, Fishbein James C, Muvarak Nidal, Lapidus Rena G, Sadowska Mariola, Edelman Martin J, Bol Guus M, Vesuna Farhad, Raman Venu, Hosmane Ramachandra S
机构信息
Laboratory for Drug Design & Synthesis, Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland, 21250, USA.
出版信息
ACS Med Chem Lett. 2010 Dec 31;2(3):252-256. doi: 10.1021/ml100281b.
Abstract
Synthesis of a series of novel, broad-spectrum anti-cancer agents containing the tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepine ring system is reported. Compounds 1, 2, 8, 11, and 12 in the series show promising in vitro antitumor activity with low micromolar IC(50)'s against prostate, lung, breast, and ovarian cancer cell lines. Some notions about structure-activity relationships and a possible mechanism of biological activity are presented. Also presented are preliminary in vivo toxicity studies of 1 using SCID mice.
摘要
报道了一系列含有三环5:7:5-稠合二咪唑并[4,5-d:4',5'-f][1,3]二氮杂卓环系统的新型广谱抗癌剂的合成。该系列中的化合物1、2、8、11和12在体外对前列腺癌、肺癌、乳腺癌和卵巢癌细胞系显示出有前景的抗肿瘤活性，其半数抑制浓度（IC50）为低微摩尔浓度。提出了一些关于构效关系和生物活性可能机制的观点。还介绍了化合物1对重症联合免疫缺陷（SCID）小鼠的初步体内毒性研究。
相似文献
1
Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System.含有三环5:7:5稠合二咪唑并二氮杂卓环系的新型广谱抗癌剂。
ACS Med Chem Lett. 2010 Dec 31;2(3):252-256. doi: 10.1021/ml100281b.
2
Structure-based drug design and potent anti-cancer activity of tricyclic 5:7:5-fused diimidazo[4,5-d:4',5'-f][1,3]diazepines.基于结构的药物设计和三环 5:7:5 稠合二咪唑并[4,5-d:4',5'-f][1,3]二氮杂�的强效抗癌活性。
Bioorg Med Chem. 2013 Feb 1;21(3):618-31. doi: 10.1016/j.bmc.2012.11.050. Epub 2012 Dec 11.
3
A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring system.一种新型的、广谱的含咪唑[4,5-e][1,3]二氮杂环庚烷环系统的抗癌化合物。
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4386-9. doi: 10.1016/j.bmcl.2010.06.061. Epub 2010 Jun 15.
4
Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system.含5:7-稠合4,6,8-三氨基咪唑并[4,5-e][1,3]二氮杂卓环系统化合物的合成、抗癌活性及构效关系分析
Bioorg Med Chem. 2016 Jun 15;24(12):2595-602. doi: 10.1016/j.bmc.2016.03.015. Epub 2016 Mar 9.
5
Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.某些多甲氧基稠合吡啶环体系作为抗肿瘤剂的合成与生物学评价
Arch Pharm (Weinheim). 2009 Oct;342(10):584-90. doi: 10.1002/ardp.200900062.
6
Synthesis and biological evaluation of novel hydrazide based cytotoxic agents.新型酰腙类细胞毒试剂的合成与生物评价。
Expert Opin Investig Drugs. 2009 May;18(5):555-68. doi: 10.1517/13543780902858815.
7
Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.合成、体外抗增殖活性及融合三环香豆素磺酸盐衍生物的计算机研究。
Eur J Med Chem. 2014 Sep 12;84:68-76. doi: 10.1016/j.ejmech.2014.06.064. Epub 2014 Jun 28.
8
A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1.一种新型的、广谱的抗肿瘤化合物，含有 1-羟基环己-2,5-二烯-4-酮基团：原阿片碱 1 中一个新的抗肿瘤药效团的揭示。
Bioorg Med Chem Lett. 2011 Jun 1;21(11):3427-30. doi: 10.1016/j.bmcl.2011.03.108. Epub 2011 Apr 5.
9
Peniapyrones A-I, Cytotoxic Tricyclic-Fused α-Pyrone Derivatives from an Endophytic F4a.青霉吡喃酮A - I，一种来自内生真菌F4a的具有细胞毒性的三环稠合α - 吡喃酮衍生物。
J Nat Prod. 2024 Jun 28;87(6):1643-1651. doi: 10.1021/acs.jnatprod.4c00383. Epub 2024 Jun 7.
10
Metal-free internal nucleophile-triggered domino route for synthesis of fused quinoxaline [1,4]-diazepine hybrids and the evaluation of their DNA binding properties.无金属内亲核试剂引发的多米诺反应途径合成并评价稠合喹喔啉[1,4]二氮杂卓杂合体的 DNA 结合性质。
Bioorg Chem. 2024 Oct;151:107694. doi: 10.1016/j.bioorg.2024.107694. Epub 2024 Aug 5.
引用本文的文献
1
DEAD-box helicase family proteins: emerging targets in digestive system cancers and advances in targeted drug development.DEAD盒解旋酶家族蛋白：消化系统癌症中的新兴靶点及靶向药物开发进展
J Transl Med. 2024 Dec 20;22(1):1120. doi: 10.1186/s12967-024-05930-0.
2
RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.RNA解旋酶DDX3调节尤因肉瘤中RAD51的定位和DNA损伤修复。
iScience. 2024 Jan 16;27(2):108925. doi: 10.1016/j.isci.2024.108925. eCollection 2024 Feb 16.
3
KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.KLHL29 介导的 DDX3X 降解通过消除三阴性乳腺癌中的细胞周期检查点来促进化学敏感性。
Oncogene. 2023 Nov;42(47):3514-3528. doi: 10.1038/s41388-023-02858-5. Epub 2023 Oct 16.
4
RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2.RK-33是宿主RNA解旋酶DDX3的小分子抑制剂，可抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的多种变体。
Front Microbiol. 2022 Aug 25;13:959577. doi: 10.3389/fmicb.2022.959577. eCollection 2022.
5
DDX3X structural analysis: Implications in the pharmacology and innate immunity.DDX3X结构分析：对药理学和先天免疫的影响
Curr Res Immunol. 2022 May 24;3:100-109. doi: 10.1016/j.crimmu.2022.05.002. eCollection 2022.
6
Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response.靶向 DDX3X 通过 dsRNA 介导的肿瘤内在 I 型干扰素反应触发抗肿瘤免疫。
Cancer Res. 2021 Jul 1;81(13):3607-3620. doi: 10.1158/0008-5472.CAN-20-3790. Epub 2021 May 3.
7
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir.DDX3 抑制剂诱导 HIV-1 感染细胞的选择性细胞死亡，导致诱导型储存库耗竭。
Nat Commun. 2021 Apr 30;12(1):2475. doi: 10.1038/s41467-021-22608-z.
8
RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma.RNA 结合蛋白作为口腔鳞状细胞癌迁移、侵袭和转移的调节剂。
Int J Mol Sci. 2020 Sep 17;21(18):6835. doi: 10.3390/ijms21186835.
9
RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X.RK-33 是一种广谱抗病毒药物，靶向 DEAD 盒 RNA 解旋酶 DDX3X。
Cells. 2020 Jan 9;9(1):170. doi: 10.3390/cells9010170.
10
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.新型 1,3,4-噻二唑类 DDX3X 抑制剂的合成与抗病毒活性。
Molecules. 2019 Nov 4;24(21):3988. doi: 10.3390/molecules24213988.
本文引用的文献
1
Hot topic: biology in anticancer treatment.
Curr Cancer Drug Targets. 2010 Feb;10(1):1-2. doi: 10.2174/156800910790980214.
2
A new generation of proto-oncogenes: cold-inducible RNA binding proteins.新一代原癌基因：冷诱导RNA结合蛋白
Biochim Biophys Acta. 2010 Jan;1805(1):43-52. doi: 10.1016/j.bbcan.2009.11.001. Epub 2009 Nov 10.
3
Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation.人类DEAD盒蛋白3在基因调控和细胞周期控制中具有多种功能，是病毒操纵的主要靶点。
Biochem Pharmacol. 2010 Feb 1;79(3):297-306. doi: 10.1016/j.bcp.2009.08.032. Epub 2009 Sep 25.
4
The first synthesis of a novel 5:7:5-fused diimidazodiazepine ring system and some of its chemical properties.新型5:7:5稠合二咪唑二氮杂卓环系的首次合成及其一些化学性质。
Org Lett. 2008 Oct 16;10(20):4681-4. doi: 10.1021/ol8020176. Epub 2008 Sep 25.
5
Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication.环扩展核苷类似物抑制RNA解旋酶和细胞内1型人类免疫缺陷病毒复制。
J Med Chem. 2008 Aug 28;51(16):5043-51. doi: 10.1021/jm800332m. Epub 2008 Aug 5.
6
Apoptotic pathways as targets for therapeutic intervention.作为治疗干预靶点的凋亡途径。
Curr Cancer Drug Targets. 2008 Mar;8(2):86. doi: 10.2174/156800908783769364.
7
Oncogenic role of DDX3 in breast cancer biogenesis.DDX3在乳腺癌发生中的致癌作用。
Oncogene. 2008 Jun 26;27(28):3912-22. doi: 10.1038/onc.2008.33. Epub 2008 Feb 11.
8
Involvement of RNA helicases p68 and p72 in colon cancer.RNA解旋酶p68和p72在结肠癌中的作用。
Cancer Res. 2007 Aug 15;67(16):7572-8. doi: 10.1158/0008-5472.CAN-06-4652.
9
Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression.p68 RNA解旋酶的磷酸化通过上调细胞周期蛋白D1和c-Myc的表达，在血小板衍生生长因子诱导的细胞增殖中发挥作用。
J Biol Chem. 2007 Jun 8;282(23):16811-9. doi: 10.1074/jbc.M610488200. Epub 2007 Apr 5.
10
DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation.DExD/H盒RNA解旋酶：在转录调控中发挥重要作用的多功能蛋白质。
Nucleic Acids Res. 2006;34(15):4206-15. doi: 10.1093/nar/gkl460. Epub 2006 Aug 25.
Zotero 插件